Lymphocyte depleted Hodgkin lymphoma is a rare subtype of Hodgkin lymphoma characterized by a predominance of Reed-Sternberg cells and a depletion of lymphocytes. This condition is clinically significant due to its aggressive nature and poor prognosis compared to other types of Hodgkin lymphoma. Accurate coding with ICD-10 Code C81.38 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat affected patients.
ICD-10 Code C81.38 represents lymphocyte depleted Hodgkin lymphoma affecting multiple lymph node sites. This subtype is associated with a higher incidence of systemic symptoms and complications. The code should be used in clinical documentation and billing when diagnosing patients with this specific form of Hodgkin lymphoma, ensuring accurate representation of the patient's condition for treatment and reimbursement purposes.
Lymphocyte depleted Hodgkin lymphoma is characterized by a significant reduction in lymphocytes, leading to a predominance of Reed-Sternberg cells. This condition often presents with advanced disease at diagnosis and requires prompt medical intervention due to its aggressive nature. The condition necessitates careful monitoring and treatment to manage symptoms and improve patient outcomes.
ICD-10 Code C81.38 is utilized in SOAP notes to document the diagnosis of lymphocyte depleted Hodgkin lymphoma. It plays a crucial role in capturing patient symptoms, assessment findings, and treatment plans, ensuring comprehensive documentation in both acute and chronic care settings.
In SOAP notes, ICD-10 Code C81.38 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of lymphocyte depleted Hodgkin lymphoma. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Lymphocyte depleted Hodgkin lymphoma requires urgent medical attention due to its aggressive nature. Treatment typically involves chemotherapy and may include radiation therapy depending on the stage of the disease.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C81.38 is crucial for billing in hospital, ER, or infectious disease care settings, ensuring accurate representation of the patient's condition.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 99214 | Established patient office visit, moderate complexity. |
| 85025 | Complete blood count with automated differential. |
Common Questions About Using ICD-10 Code C81.38 for Lymphocy depleted Hodgkin lymphoma, nodes mult site
What are the common symptoms of lymphocyte depleted Hodgkin lymphoma?
Common symptoms include persistent fatigue, unexplained weight loss, night sweats, and swollen lymph nodes. Patients may also experience fever and itching.
How is lymphocyte depleted Hodgkin lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes to identify Reed-Sternberg cells.
What treatment options are available for lymphocyte depleted Hodgkin lymphoma?
Treatment usually involves chemotherapy, often combined with radiation therapy, depending on the stage of the disease. Supportive care is also important.
Is lymphocyte depleted Hodgkin lymphoma contagious?
No, lymphocyte depleted Hodgkin lymphoma is not contagious. It is a type of cancer that arises from lymphatic tissue and is not spread from person to person.
Clinical Notes
SOAP notes
DAP notes
AI medical notes